Tenofovir registered in Russia

2 April 2010. Related: Treatment access.

On 30 March 2010, the Russian healthcare authorities registered  a generic formulation of tenofovir 300 mg, manufactured by Hetero Drugs Ltd, India, to be distributed by MakizPharma in Russia.

However, although tenofovir will now be available, this is only through commercial individual purchase because it has yet  to be included in either the national HIV treatment standards, or in the list of the government procurement for 2010.

Source: Russian Community of PLHIV
http://www.positivenet.ru